Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
R. Comino Delgado, S. Prieto Alcedo.
Alcohol y cáncer de mama.
Prog Obstet Ginecol, 45 (2002), pp. 541-548
[2.]
A. Goldhirsh, J.H. Glick, R.D. Gelbert.
Meeting highlights: international consensus panel on the treatment of primary breast cancer: seventh international conference on adjuvant therapy of primary breast cancer.
J Clin Oncol, 19 (2001), pp. 3817-3827
[3.]
P. Eifel, J.A. Axelson, J. Costa.
National Institutes of Health consensus development conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
J Natl Cancer Inst, 93 (2001), pp. 979-989
[4.]
Bazarra-Castro MA, Bazarra A. Cáncer de mama: ¿dónde nos encontramos? [en prensa]. Acta Gin
[5.]
J. Botella Llusiá.
Señales intracelulares.
Acta Gin, 59 (2002), pp. 190
[6.]
J. Botella Llusiá.
Acciones no feminizantes de los estrógenos.
Acta Gin, 59 (2002), pp. 191-194
[7.]
A. Bazarra.
¿Son los estrógenos carcinogenos?.
Acta Gin, 59 (2002), pp. 215-216
[8.]
E. Thurfjell.
Perspective: breast density and the risk of breast cancer.
N Engl J Med, 347 (2002), pp. 866
[9.]
J. Cui, A.C. Antiniou, G.S. Dite.
After BRCA1 and BRCA2 –what next?.
Multifactorial segregation analysis of three-generation, population-based Australian families affected by female breast cancer. Am J Human Genet, 21 (2001), pp. 1-8
[10.]
N.F. Boyd, S.G. Dite, J. Stone.
Heritability of mammographic density, a risk factor for breast cancer.
N Engl J Med, 347 (2002), pp. 886-894
[11.]
Y.P. Guo, L. Martin, W. Hanna.
Growth factors and stromal matrix proteins associated with mammographic densities.
Cancer Epidemiol Biomarkers Prev, 10 (2001), pp. 243-248
[12.]
C. Byrne, S.E. Hankinson, G.A. Colditz.
Plasma prolactin and mammographic density in postmenopausal women.
Proc Am Assoc Cancer Res, 42 (2001), pp. 153
[13.]
M. Morrow.
Rational local therapy for breast cancer.
N Engl J Med, 347 (2002), pp. 1270-1271
[14.]
U. Veronesi, N. Cascinelli, L. Mariani.
Twuenty-year follow-up of a ramdomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.
N Engl J Med, 347 (2002), pp. 1227-1232
[15.]
B. Fisher, S. Anderson, J. Bryant.
Twenty-year follow-up of a ramdomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.
N Engl J Med, 347 (2002), pp. 1233-1241
[16.]
A.C. Voogd, M. Nielsen, J.L. Peterse.
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.
J Clin Oncol, 19 (2001), pp. 1688-1697
[17.]
R.L. Sutherland, E.A. Musgrove.
Cyclin E and prognosis in patients with breast cancer.
N Engl J Med, 347 (2002), pp. 1546-1547
[18.]
K. Keyomarsi, S.L. Tucker, T.A. Buchhold.
Cyclin E and survival in patients with breast cancer.
N Engl J Med, 347 (2002), pp. 1566-1575
[19.]
A.C. Voogd, M. Nielsen, J.l. Peterse.
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European ramdomized trials. [Fe de errors: J Clin Oncol 2001:2583.].
J Clin Oncol, 19 (2001), pp. 1688-1697
[20.]
D. Porter, N. Zhang, C. Danse.
Tumor-specific prooteolytic processing of cyclin E generates hyperactive low-molecularweight forms.
Mol Cell Biol, 21 (2001), pp. 6254-6269
[21.]
R. Donnellan, I. Kleinschmidt, R. Chetty.
Cyclin and inmunoexpresión in breast ductal carcinoma: pathologic correlation and prognostic implications.
Hum Pathol, 32 (2001), pp. 8-94
[22.]
R.M. Harwell, D.C. Porter, C. Danes, K. Keyomarsi.
Processing of cyclin E differs between normal and tumor breast cells.
Cancer Res, 60 (2000), pp. 187-220
[23.]
G. Sauter, R. Simon.
Predictive molecular pathology.
N Engl J Med, 347 (2002), pp. 1995-1996
[24.]
M.J. Van de Vijver, Y.D. He, M.J. Van't Veer.
A gene-expresion signature as a predictor of survival in breast cancer.
N Engl J Med, 347 (2002), pp. 1999-2009
Copyright © 2003. Sociedad Española de Ginecología y Obstetricia